Diana Bowman – författare

Nanotechnology Environmental Health and Safety, Second Edition focuses not only on the impact of nanotechnology and the discipline of nanotoxicity, but also explains each of these disciplines through in the context of management requirements and via risk scenarios - providing an overview of regulation, risk management, and exposure. Contributors thoroughly explain environmental health and safety (EHS) issues, financial implications, foreseeable risks (e.g., exposure, dose, hazards of nanomaterials), occupational hygiene, and consumer protection.Key new chapters have been included covering eco-toxicity, nanomedicine, informatics, and future threats. New case studies have also been added, including a chapter on the impact of nanosilver on the environment, as well as an assessment of how well lessons have been learned from the past, such as in the case of asbestos. The book also makes a business case for the importance of proactive EHS management - essential reading for existing or prospective producers of nanoscale products. Practical guidance on risk management and mitigation across different legislative frameworks worldwide Reviews toxicological studies and industrial initiatives, supported by numerous case studies Includes extensive new material on the implications of nanotechnology for medicine, energy and food, as well as assessing future threats

Nanotechnology Environmental Health and Safety tackles - in depth and in breadth - the complex and evolving issues pertaining to nanotechnology's environmental health and safety (EHS). The chapters are authored by leaders in their respective fields, providing thorough analysis of their research areas. The diverse spectrum of topics include nanotechnology EHS issues, financial implications, foreseeable risks including exposure, dosage and hazards, and the implications of occupational hygiene precautions and consumer protections.

The book includes real-world case studies, wherever practical, to illustrate specific issues and scenarios encountered by stakeholders positioned on the front-lines of nanotechnology-enabled industries. These case studies will appeal to, and resonate with, laboratory scientists, business leaders, regulators, service providers, and postgraduate researchers.

Reviews toxicological studies and industrial initiatives, supported by numerous case studies Covers new generation of nanoparticles and significantly expands on existing material from second edition Only edited volume to collect research on the regulatory and risk implications of a wide array of industrial, environmental and consumer nanomaterials

A cutting-edge analysis of the global issues surrounding modern reproductive technologies Advances in assisted reproductive technologies have sparked global policy debates since the birth of the first so-called "test tube baby" in 1978. Today, mitochondrial replacement therapies represent the most recent advancement in assisted reproductive technologies, allowing some women with mitochondrial diseases to birth babies without those diseases. In the past decade, mitochondrial replacement therapies have captured public sentiment, reigniting debates around social views of reproductive rights and the appropriate legal and political response.Reproduction Reborn guides readers through the history and science of mitochondrial replacement therapies and the various attempts to control them. Leading experts from medicine, genetics, ethics, law, and policy explore the influence of public debate on the evolving shape of these technologies and their subsequent regulation. They highlight case studies from both developed and developing countries across the globe, including recent legislation in Australia and China. They further identify the ethical, legal, and societal norms that need to be addressed by policymakers and communities as more and more people seek to gain access to these treatments. Given the importance of reproduction in family life and cultural identity, clinicians and policymakers must understand how regulatory regimes around mitochondrial replacement therapies have evolved to illuminate the processes and challenges of governing reproduction in a fast-moving world.Informative and global in scope, Reproduction Reborn explores how advancements in assisted reproductive technologies challenge core values surrounding the rights and responsibilities of modern-day family units.

A cutting-edge analysis of the global issues surrounding modern reproductive technologies Advances in assisted reproductive technologies have sparked global policy debates since the birth of the first so-called "test tube baby" in 1978. Today, mitochondrial replacement therapies represent the most recent advancement in assisted reproductive technologies, allowing some women with mitochondrial diseases to birth babies without those diseases. In the past decade, mitochondrial replacement therapies have captured public sentiment, reigniting debates around social views of reproductive rights and the appropriate legal and political response.Reproduction Reborn guides readers through the history and science of mitochondrial replacement therapies and the various attempts to control them. Leading experts from medicine, genetics, ethics, law, and policy explore the influence of public debate on the evolving shape of these technologies and their subsequent regulation. They highlight case studies from both developed and developing countries across the globe, including recent legislation in Australia and China. They further identify the ethical, legal, and societal norms that need to be addressed by policymakers and communities as more and more people seek to gain access to these treatments. Given the importance of reproduction in family life and cultural identity, clinicians and policymakers must understand how regulatory regimes around mitochondrial replacement therapies have evolved to illuminate the processes and challenges of governing reproduction in a fast-moving world.Informative and global in scope, Reproduction Reborn explores how advancements in assisted reproductive technologies challenge core values surrounding the rights and responsibilities of modern-day family units.

Nanotechnology Environmental Health and Safety: Risks, Regulation, and Management, Fourth Edition explores the complex and evolving issues pertaining to nanotechnology's environmental health and safety (EHS). With significant advancements in nanomaterial usage, such as graphene and cellulose, and the intersection with fields like agriculture, climate change, medicine, and personal care products, this new edition provides insights into the current state of nanotechnology twenty years after pivotal health and safety discussions. It offers a preliminary roadmap for upcoming advancements, showcases the influence of nanotechnology on the emergence of new technologies, and raises vital questions about the broad application of nanotechnology in real-world settings.Additionally, this edition introduces new topics like AI and nanomaterials, reflecting the ever-evolving landscape of nanotechnology. This thoroughly revised edition also incorporates real-world case studies to offer practical examples of specific challenges and scenarios faced by stakeholders at the forefront of nanotechnology-driven industries, making it an invaluable resource to laboratory scientists, business leaders, regulators, service providers, and postgraduate researchers.Covers the new generation of nanoparticles and significantly expands on existing material from third editionReviews toxicological studies and industrial initiatives, all supported by numerous case studiesProvides the only edited volume to collect research on the regulatory and risk implications of a wide array of industrial, environmental, and consumer nanomaterials

Nanotechnology Environmental Health and Safety, Second Edition focuses not only on the impact of nanotechnology and the discipline of nanotoxicity, but also explains each of these disciplines through in the context of management requirements and via risk scenarios - providing an overview of regulation, risk management, and exposure. Contributors thoroughly explain environmental health and safety (EHS) issues, financial implications, foreseeable risks (e.g., exposure, dose, hazards of nanomaterials), occupational hygiene, and consumer protection.Key new chapters have been included covering eco-toxicity, nanomedicine, informatics, and future threats. New case studies have also been added, including a chapter on the impact of nanosilver on the environment, as well as an assessment of how well lessons have been learned from the past, such as in the case of asbestos. The book also makes a business case for the importance of proactive EHS management - essential reading for existing or prospective producers of nanoscale products. Practical guidance on risk management and mitigation across different legislative frameworks worldwide Reviews toxicological studies and industrial initiatives, supported by numerous case studies Includes extensive new material on the implications of nanotechnology for medicine, energy and food, as well as assessing future threats